Identification of a robust gene signature that predicts breast cancer outcome in independent data sets

BMC Cancer

Table 3 Classification Rates within Treatment Subgroups¹

Gene Set	Radiation treated N = 30	No Radiation N = 25	Chemo treated N = 27	No Chemo N = 28	Hormone therapy N = 40	No Hormone N = 15
PAM	67%	76%	56%	86%	75%	67%
Correlation	73%	76%	59%	89%	72%	73%
Overlap	67%	72%	59%	79%	75%	60%

¹ Correct leave-one-out cross-validation classification rates with gene re-sampling into good and poor outcome groups in 55 tumors

ISSN: 1471-2407